Marliese Alexander

Medical University of South Carolina — United States

Medicine · Health Sciences

21h-index1.4kcitations148works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(32), Lung Cancer Research Studies(20), Lung Cancer Diagnosis and Treatment(19), Venous Thromboembolism Diagnosis and Management(17), Neutropenia and Cancer Infections(11)

Publications148 total

Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis
Lung Cancer·2025
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
Clinical Drug Investigation·2025Open Access
Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer
Lung Cancer·2025
EP.17.02 Treatment and Survival Outcomes for Indigenous Australians Within the Victorian Lung Cancer Registry
Journal of Thoracic Oncology·2025
MA06.06 Overall Survival Among Patients With Oncogene Driven Lung Cancers Treated on Clinical Trials Compared to Standard Care
Journal of Thoracic Oncology·2025
A randomized controlled trial of cognitive behavioral therapy and bright light therapy for insomnia and fatigue during breast cancer treatment: SleepCaRe trial.
Journal of Clinical Oncology·2025
A randomized controlled trial: Evaluating whether a cognitive behavioral internet-delivered intervention targeting emotion regulation improves health-related quality of life in cancer survivors.
Health Psychology·2025· 2 citedOpen Access
Phenoconversion of <i>CYP3A4</i>, <i>CYP2C19</i> and <i>CYP2D6</i> in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the <scp>PEGASUS</scp> Study
Clinical and Translational Science·2025Open Access
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
Clinical and Translational Science·2025· 1 citedOpen Access
98P: Exploratory analysis showed increased overall survival among non-small cell lung cancer (NSCLC) patients with mutated KRAS compared with wildtype KRAS in a phase II trial of mecbotamab vedotin (CAB-AXL-ADC)
Journal of Thoracic Oncology·2025· 1 citedOpen Access
Feasibility and population exposure of 5‐fluorouracil using therapeutic drug monitoring (PREDICT‐5FU): A multicentre clinical trial
British Journal of Clinical Pharmacology·2025· 4 citedOpen Access
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort Study
Clinical Lung Cancer·2025· 1 cited
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
Lung Cancer·2025· 8 cited
Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives
Genetics in Medicine Open·2025Open Access
Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial
JMIR Formative Research·2024· 4 citedOpen Access
Pharmacogenetic‐guided dosing for fluoropyrimidine (<i>DPYD</i>) and irinotecan (<i>UGT1A1*28</i>) chemotherapies for patients with cancer (<scp>PACIFIC</scp>‐<scp>PGx</scp>): A multicenter clinical trial
Clinical and Translational Science·2024· 4 citedOpen Access
OP-7 The timing of opioid initiation and switching in advanced cancer
Oral Presentations·2024Open Access
Co-designing a motivational interviewing training platform to enhance oncology healthcare professional communication
PEC Innovation·2024· 1 citedOpen Access
Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial (Preprint)
2024Open Access
Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol
BMJ Open·2024· 4 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Benjamin Solomon(18), Kate Burbury(13), David Ball(9), Sue Kirsa(7), Senthil Lingaratnam(7), Rory Wolfe(6), Michael MacManus(6), Nick Pavlakis(5), Thomas John(5), Malinda Itchins(5), Ann Officer(4), Fanny Franchini(4), Danny Rischin(4), Steven Kao(4), Grace Chazan(4), Sue Evans(3), Maarten J. IJzerman(3), James D Mellor(3), Renée Manser(3), Bernhard Riedel(3)